Nygen, a pioneering company dedicated to transforming the landscape of single-cell genomics data analytics, has successfully raised $7.5 million in its latest funding round. This significant investment underscores the enthusiasm and confidence investors have in Nygen’s mission to democratize access to powerful genomic technologies. With this influx of resources, Nygen aims to enhance its open-access data infrastructure, CellHub, allowing researchers across the globe to analyze and explore vast datasets with improved collaboration between bench and computational scientists. By prioritizing accessibility and the development of accurate, reproducible analytics tools, Nygen is poised to drive scientific innovation and breakthroughs in genomics. The funding will further support the integration of multi-modal and multi-omic analyses, ensuring that researchers can derive comprehensive insights from the complex world of single-cell data. Backed by partnerships with leading academic and research institutions, Nygen continues to push the envelope of what’s achievable in this cutting-edge field. The company’s team of experienced professionals is dedicated to developing sophisticated algorithms and a state-of-the-art cloud-based infrastructure while maintaining stringent security and privacy measures to safeguard researchers' data. Nygen invites stakeholders, researchers, and scientific enthusiasts to join them on this transformative journey to unlock the full potential of single-cell genomics analytics. With this latest funding round, Nygen is equipped to lead the way toward democratizing access to these vital tools and fostering a collaborative scientific community that thrives on shared knowledge and innovation.





